title: HCV+ donors: should they be used for organ transplantation?
authors.affiliation: National Institute of Transplantation, USC School of Medicine, Los Angeles 90057.
authors.forename: S
authors.initials: S
authors.lastname: Aswad
authors.forename: E
authors.initials: E
authors.lastname: Obispo
authors.forename: R G
authors.initials: RG
authors.lastname: Mendez
authors.forename: R
authors.initials: R
authors.lastname: Mendez
mesh_terms: D000328:Adult; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006526:Hepatitis C / Q000635:transmission*; D006801:Humans; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution; D009927:Tissue and Organ Procurement